Denise Epperson, MD
Psychiatry · Shelbyville, KYNPI 1851440267
Payments from drug & device makers
Across 53 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$192
- Lundbeck LLC$145
- Otsuka America Pharmaceutical, Inc.$121
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$85
- Noven Therapeutics, LLC$77
- Neurocrine Biosciences, Inc.$70
- plus $267 from 9 others
What the payments were for
- Food & beverage$957100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 12 | $192 |
| Lundbeck LLC | 7 | $145 |
| Otsuka America Pharmaceutical, Inc. | 6 | $121 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $85 |
| Noven Therapeutics, LLC | 4 | $77 |
| Neurocrine Biosciences, Inc. | 4 | $70 |
| AbbVie | 4 | $69 |
| Tris Pharma Inc | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Bausch Health US, LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Corium, LLC | 3 | $18 |
| Neos Therapeutics, LP | 1 | $14 |
How this compares
$957 in reported general payments places this provider in the 65th percentile of 348 psychiatry providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ziprasidone Hcl | 12 | $1,329 |
| Olanzapine | 29 | $881 |
| Aripiprazole | 13 | $784 |
| Quetiapine Fumarate | 45 | $505 |
| Divalproex Sodium | 16 | $483 |
| Bupropion XlBupropion Hcl | 32 | $343 |
| Lamotrigine | 59 | $337 |
| Duloxetine Hcl | 11 | $217 |
| Risperidone | 15 | $216 |
| Escitalopram Oxalate | 38 | $194 |
| Benztropine Mesylate | 12 | $172 |
| Buspirone Hcl | 13 | $158 |
| Sertraline Hcl | 26 | $125 |
| Trazodone Hcl | 27 | $114 |
| Hydroxyzine Hcl | 15 | $111 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Shelbyville
- Carmen PintoElizabethtown$1.7M
- Rifaat El-MallakhLouisville$1.7M
- Robert StewartLouisville$651K
- Mark WrightLexington$637K
- Carol MillerFrankfort$462K
- Ali FarooquiLouisville$393K
- Balakumar KrishnaswamyHazard$162K
- Steven CroleyLexington$151K
- Joseph HarrisonOwensboro$131K
- Stephanie HallLouisville$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.